Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation

The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2002-04, Vol.277 (16), p.13682-13692
Hauptverfasser: Voisin, Mathieu-Benoı̂t, Bitard, Juliette, Daburon, Sophie, Moreau, Jean-François, Taupin, Jean-Luc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 13692
container_issue 16
container_start_page 13682
container_title The Journal of biological chemistry
container_volume 277
creator Voisin, Mathieu-Benoı̂t
Bitard, Juliette
Daburon, Sophie
Moreau, Jean-François
Taupin, Jean-Luc
description The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-like modules of around 100 amino acids each. The gp190 is among the very few members of this large family to contain two CRH domains. The membrane-distal one (herein called D1) is followed by an immunoglobulin-like domain, a membrane-proximal CRH domain called D2, and three type III fibronectin-like repeats. A minimal D1IgD2 fragment is required for binding LIF. By using transmembrane forms of deletion mutants in gp190 ectodomain, we demonstrated that removal of D1 led to spontaneous activation of the receptor and that this property was devoted to a peptidic sequence localized within the last 42 amino acids of the carboxyl-terminal module of D2. By using soluble forms of deletion mutants made by progressive truncations from the end of the D1IgD2 fragment, we demonstrated that the carboxyl-terminal module of D2 was dispensable for LIF binding and that the correct conformation of the D1Ig fragment required a full amino-terminal module of D2. Therefore, the two constitutive modules of the membrane-proximal CRH domain D2 of gp190 fulfill two distinct roles in gp190 function, i.e. in stabilizing the conformation of gp190 allowing LIF binding and in activating the receptor.
doi_str_mv 10.1074/jbc.M111624200
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04669425v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925819609634</els_id><sourcerecordid>18310635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-b06c5fccc25c108bf9896166dc259a6eeb118548303afe9c4dd852f5b64c7f0f3</originalsourceid><addsrcrecordid>eNp1kV9v0zAUxSMEYmXwyiPyA0JCWoqdP07yWArdJqVCgiHxZjnOdestsTs7ael35ENxu5btCb_Yvv6d66tzougto1NGi-zTbaOmS8YYT7KE0mfRhNEyjdOc_XoeTShNWFwleXkWvQrhluLKKvYyOmOsTLMirSbRnx-wkV4OQBajVYNxNhDtPBnWQG52jixdO3YQiNMPpSX0jZcW4o13v00vOzLfD-7OWCCfjW2NXZEvrpfGHgSX3V45BAfAO6voxUOLGsY76I0k13ZtGjM4vycLqXAntduRmdbGmmFPvoOCDVYvCKprs5K2ffzjcP73TmY49lYeRn8dvdCyC_DmtJ9HPxdfb-ZXcf3t8no-q2OVFdkQN5SrXCulklyhXY2uyoozzlssVJIDNOhPnpUpTaWGSmVtW-aJzhueqUJTnZ5HH49917ITG48--L1w0oirWS0ONZpxXmVJvmXIfjiyaMT9CGEQvQkKug5ddGMQmASjPM0RnB5B5V0IHvRjZ0bFIWuBWYunrFHw7tR5bHpon_BTuAi8P41pVuud8SAa49QaepEUhWBcsJSXCWLlEQO0bGvAi6AMWAUtStQgWmf-N8JfVJHF5w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18310635</pqid></control><display><type>article</type><title>Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Voisin, Mathieu-Benoı̂t ; Bitard, Juliette ; Daburon, Sophie ; Moreau, Jean-François ; Taupin, Jean-Luc</creator><creatorcontrib>Voisin, Mathieu-Benoı̂t ; Bitard, Juliette ; Daburon, Sophie ; Moreau, Jean-François ; Taupin, Jean-Luc</creatorcontrib><description>The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-like modules of around 100 amino acids each. The gp190 is among the very few members of this large family to contain two CRH domains. The membrane-distal one (herein called D1) is followed by an immunoglobulin-like domain, a membrane-proximal CRH domain called D2, and three type III fibronectin-like repeats. A minimal D1IgD2 fragment is required for binding LIF. By using transmembrane forms of deletion mutants in gp190 ectodomain, we demonstrated that removal of D1 led to spontaneous activation of the receptor and that this property was devoted to a peptidic sequence localized within the last 42 amino acids of the carboxyl-terminal module of D2. By using soluble forms of deletion mutants made by progressive truncations from the end of the D1IgD2 fragment, we demonstrated that the carboxyl-terminal module of D2 was dispensable for LIF binding and that the correct conformation of the D1Ig fragment required a full amino-terminal module of D2. Therefore, the two constitutive modules of the membrane-proximal CRH domain D2 of gp190 fulfill two distinct roles in gp190 function, i.e. in stabilizing the conformation of gp190 allowing LIF binding and in activating the receptor.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M111624200</identifier><identifier>PMID: 11834739</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Amino Acid Sequence ; Animals ; Antibodies, Monoclonal ; Antibodies, Monoclonal - metabolism ; Antigens, Neoplasm ; Antigens, Neoplasm - chemistry ; Antigens, Neoplasm - metabolism ; Cell Division ; Cell Line ; Cell Membrane ; Cell Membrane - metabolism ; CHO Cells ; COS Cells ; Cricetinae ; Cytokines ; Cytokines - metabolism ; Dimerization ; DNA-Binding Proteins ; DNA-Binding Proteins - metabolism ; Dose-Response Relationship, Drug ; Enzyme-Linked Immunosorbent Assay ; Fibronectins ; Fibronectins - metabolism ; Flow Cytometry ; Gene Deletion ; glycoprotein gp190 ; Growth Inhibitors ; Growth Inhibitors - pharmacology ; Humans ; Interleukin-6 ; Leukemia Inhibitory Factor ; Leukemia Inhibitory Factor Receptor alpha Subunit ; LIF protein ; Life Sciences ; Ligands ; Lymphokines ; Lymphokines - pharmacology ; Mice ; Molecular Sequence Data ; Mutation ; Phosphorylation ; Protein Binding ; Protein Conformation ; Protein Structure, Tertiary ; Receptors, Cytokine ; Receptors, Cytokine - chemistry ; Receptors, Cytokine - metabolism ; Receptors, OSM-LIF ; STAT3 Transcription Factor ; Trans-Activators ; Trans-Activators - metabolism ; Transfection</subject><ispartof>The Journal of biological chemistry, 2002-04, Vol.277 (16), p.13682-13692</ispartof><rights>2002 © 2002 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-b06c5fccc25c108bf9896166dc259a6eeb118548303afe9c4dd852f5b64c7f0f3</citedby><cites>FETCH-LOGICAL-c474t-b06c5fccc25c108bf9896166dc259a6eeb118548303afe9c4dd852f5b64c7f0f3</cites><orcidid>0000-0001-6626-3522</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11834739$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04669425$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Voisin, Mathieu-Benoı̂t</creatorcontrib><creatorcontrib>Bitard, Juliette</creatorcontrib><creatorcontrib>Daburon, Sophie</creatorcontrib><creatorcontrib>Moreau, Jean-François</creatorcontrib><creatorcontrib>Taupin, Jean-Luc</creatorcontrib><title>Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-like modules of around 100 amino acids each. The gp190 is among the very few members of this large family to contain two CRH domains. The membrane-distal one (herein called D1) is followed by an immunoglobulin-like domain, a membrane-proximal CRH domain called D2, and three type III fibronectin-like repeats. A minimal D1IgD2 fragment is required for binding LIF. By using transmembrane forms of deletion mutants in gp190 ectodomain, we demonstrated that removal of D1 led to spontaneous activation of the receptor and that this property was devoted to a peptidic sequence localized within the last 42 amino acids of the carboxyl-terminal module of D2. By using soluble forms of deletion mutants made by progressive truncations from the end of the D1IgD2 fragment, we demonstrated that the carboxyl-terminal module of D2 was dispensable for LIF binding and that the correct conformation of the D1Ig fragment required a full amino-terminal module of D2. Therefore, the two constitutive modules of the membrane-proximal CRH domain D2 of gp190 fulfill two distinct roles in gp190 function, i.e. in stabilizing the conformation of gp190 allowing LIF binding and in activating the receptor.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies, Monoclonal</subject><subject>Antibodies, Monoclonal - metabolism</subject><subject>Antigens, Neoplasm</subject><subject>Antigens, Neoplasm - chemistry</subject><subject>Antigens, Neoplasm - metabolism</subject><subject>Cell Division</subject><subject>Cell Line</subject><subject>Cell Membrane</subject><subject>Cell Membrane - metabolism</subject><subject>CHO Cells</subject><subject>COS Cells</subject><subject>Cricetinae</subject><subject>Cytokines</subject><subject>Cytokines - metabolism</subject><subject>Dimerization</subject><subject>DNA-Binding Proteins</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Fibronectins</subject><subject>Fibronectins - metabolism</subject><subject>Flow Cytometry</subject><subject>Gene Deletion</subject><subject>glycoprotein gp190</subject><subject>Growth Inhibitors</subject><subject>Growth Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Interleukin-6</subject><subject>Leukemia Inhibitory Factor</subject><subject>Leukemia Inhibitory Factor Receptor alpha Subunit</subject><subject>LIF protein</subject><subject>Life Sciences</subject><subject>Ligands</subject><subject>Lymphokines</subject><subject>Lymphokines - pharmacology</subject><subject>Mice</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Phosphorylation</subject><subject>Protein Binding</subject><subject>Protein Conformation</subject><subject>Protein Structure, Tertiary</subject><subject>Receptors, Cytokine</subject><subject>Receptors, Cytokine - chemistry</subject><subject>Receptors, Cytokine - metabolism</subject><subject>Receptors, OSM-LIF</subject><subject>STAT3 Transcription Factor</subject><subject>Trans-Activators</subject><subject>Trans-Activators - metabolism</subject><subject>Transfection</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kV9v0zAUxSMEYmXwyiPyA0JCWoqdP07yWArdJqVCgiHxZjnOdestsTs7ael35ENxu5btCb_Yvv6d66tzougto1NGi-zTbaOmS8YYT7KE0mfRhNEyjdOc_XoeTShNWFwleXkWvQrhluLKKvYyOmOsTLMirSbRnx-wkV4OQBajVYNxNhDtPBnWQG52jixdO3YQiNMPpSX0jZcW4o13v00vOzLfD-7OWCCfjW2NXZEvrpfGHgSX3V45BAfAO6voxUOLGsY76I0k13ZtGjM4vycLqXAntduRmdbGmmFPvoOCDVYvCKprs5K2ffzjcP73TmY49lYeRn8dvdCyC_DmtJ9HPxdfb-ZXcf3t8no-q2OVFdkQN5SrXCulklyhXY2uyoozzlssVJIDNOhPnpUpTaWGSmVtW-aJzhueqUJTnZ5HH49917ITG48--L1w0oirWS0ONZpxXmVJvmXIfjiyaMT9CGEQvQkKug5ddGMQmASjPM0RnB5B5V0IHvRjZ0bFIWuBWYunrFHw7tR5bHpon_BTuAi8P41pVuud8SAa49QaepEUhWBcsJSXCWLlEQO0bGvAi6AMWAUtStQgWmf-N8JfVJHF5w</recordid><startdate>20020419</startdate><enddate>20020419</enddate><creator>Voisin, Mathieu-Benoı̂t</creator><creator>Bitard, Juliette</creator><creator>Daburon, Sophie</creator><creator>Moreau, Jean-François</creator><creator>Taupin, Jean-Luc</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-6626-3522</orcidid></search><sort><creationdate>20020419</creationdate><title>Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation</title><author>Voisin, Mathieu-Benoı̂t ; Bitard, Juliette ; Daburon, Sophie ; Moreau, Jean-François ; Taupin, Jean-Luc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-b06c5fccc25c108bf9896166dc259a6eeb118548303afe9c4dd852f5b64c7f0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies, Monoclonal</topic><topic>Antibodies, Monoclonal - metabolism</topic><topic>Antigens, Neoplasm</topic><topic>Antigens, Neoplasm - chemistry</topic><topic>Antigens, Neoplasm - metabolism</topic><topic>Cell Division</topic><topic>Cell Line</topic><topic>Cell Membrane</topic><topic>Cell Membrane - metabolism</topic><topic>CHO Cells</topic><topic>COS Cells</topic><topic>Cricetinae</topic><topic>Cytokines</topic><topic>Cytokines - metabolism</topic><topic>Dimerization</topic><topic>DNA-Binding Proteins</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Fibronectins</topic><topic>Fibronectins - metabolism</topic><topic>Flow Cytometry</topic><topic>Gene Deletion</topic><topic>glycoprotein gp190</topic><topic>Growth Inhibitors</topic><topic>Growth Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Interleukin-6</topic><topic>Leukemia Inhibitory Factor</topic><topic>Leukemia Inhibitory Factor Receptor alpha Subunit</topic><topic>LIF protein</topic><topic>Life Sciences</topic><topic>Ligands</topic><topic>Lymphokines</topic><topic>Lymphokines - pharmacology</topic><topic>Mice</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Phosphorylation</topic><topic>Protein Binding</topic><topic>Protein Conformation</topic><topic>Protein Structure, Tertiary</topic><topic>Receptors, Cytokine</topic><topic>Receptors, Cytokine - chemistry</topic><topic>Receptors, Cytokine - metabolism</topic><topic>Receptors, OSM-LIF</topic><topic>STAT3 Transcription Factor</topic><topic>Trans-Activators</topic><topic>Trans-Activators - metabolism</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Voisin, Mathieu-Benoı̂t</creatorcontrib><creatorcontrib>Bitard, Juliette</creatorcontrib><creatorcontrib>Daburon, Sophie</creatorcontrib><creatorcontrib>Moreau, Jean-François</creatorcontrib><creatorcontrib>Taupin, Jean-Luc</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Voisin, Mathieu-Benoı̂t</au><au>Bitard, Juliette</au><au>Daburon, Sophie</au><au>Moreau, Jean-François</au><au>Taupin, Jean-Luc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2002-04-19</date><risdate>2002</risdate><volume>277</volume><issue>16</issue><spage>13682</spage><epage>13692</epage><pages>13682-13692</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-like modules of around 100 amino acids each. The gp190 is among the very few members of this large family to contain two CRH domains. The membrane-distal one (herein called D1) is followed by an immunoglobulin-like domain, a membrane-proximal CRH domain called D2, and three type III fibronectin-like repeats. A minimal D1IgD2 fragment is required for binding LIF. By using transmembrane forms of deletion mutants in gp190 ectodomain, we demonstrated that removal of D1 led to spontaneous activation of the receptor and that this property was devoted to a peptidic sequence localized within the last 42 amino acids of the carboxyl-terminal module of D2. By using soluble forms of deletion mutants made by progressive truncations from the end of the D1IgD2 fragment, we demonstrated that the carboxyl-terminal module of D2 was dispensable for LIF binding and that the correct conformation of the D1Ig fragment required a full amino-terminal module of D2. Therefore, the two constitutive modules of the membrane-proximal CRH domain D2 of gp190 fulfill two distinct roles in gp190 function, i.e. in stabilizing the conformation of gp190 allowing LIF binding and in activating the receptor.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11834739</pmid><doi>10.1074/jbc.M111624200</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6626-3522</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2002-04, Vol.277 (16), p.13682-13692
issn 0021-9258
1083-351X
language eng
recordid cdi_hal_primary_oai_HAL_hal_04669425v1
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Amino Acid Sequence
Animals
Antibodies, Monoclonal
Antibodies, Monoclonal - metabolism
Antigens, Neoplasm
Antigens, Neoplasm - chemistry
Antigens, Neoplasm - metabolism
Cell Division
Cell Line
Cell Membrane
Cell Membrane - metabolism
CHO Cells
COS Cells
Cricetinae
Cytokines
Cytokines - metabolism
Dimerization
DNA-Binding Proteins
DNA-Binding Proteins - metabolism
Dose-Response Relationship, Drug
Enzyme-Linked Immunosorbent Assay
Fibronectins
Fibronectins - metabolism
Flow Cytometry
Gene Deletion
glycoprotein gp190
Growth Inhibitors
Growth Inhibitors - pharmacology
Humans
Interleukin-6
Leukemia Inhibitory Factor
Leukemia Inhibitory Factor Receptor alpha Subunit
LIF protein
Life Sciences
Ligands
Lymphokines
Lymphokines - pharmacology
Mice
Molecular Sequence Data
Mutation
Phosphorylation
Protein Binding
Protein Conformation
Protein Structure, Tertiary
Receptors, Cytokine
Receptors, Cytokine - chemistry
Receptors, Cytokine - metabolism
Receptors, OSM-LIF
STAT3 Transcription Factor
Trans-Activators
Trans-Activators - metabolism
Transfection
title Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T00%3A44%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Separate%20Functions%20for%20the%20Two%20Modules%20of%20the%20Membrane-proximal%20Cytokine%20Binding%20Domain%20of%20Glycoprotein%20190,%20the%20Leukemia%20Inhibitory%20Factor%20Low%20Affinity%20Receptor,%20in%20Ligand%20Binding%20and%20Receptor%20Activation&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Voisin,%20Mathieu-Beno%C4%B1%CC%82t&rft.date=2002-04-19&rft.volume=277&rft.issue=16&rft.spage=13682&rft.epage=13692&rft.pages=13682-13692&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M111624200&rft_dat=%3Cproquest_hal_p%3E18310635%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18310635&rft_id=info:pmid/11834739&rft_els_id=S0021925819609634&rfr_iscdi=true